Autopsy report · NCT01164046

Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism

“Due to slow inclusion of patients”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 3 years 11 months before it stopped.
• 56 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

University Medical Center Groningen

Sponsor type

University, hospital or other

Conditions

Venous Thromboembolism; Neoplasms

Interventions

low molecular weight heparin; vitamin K antagonists

Participants

56

Sites

14

Countries

Canada, Germany, Italy, Netherlands, United States

Trials that died the same way

• Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
  “Due to slow accrual of patients” (84% match in meaning)
• Cetrotide Treatment Optimization
  “Due to limited rate of patient inclusion” (79% match in meaning)
• Exercise for Improving Prostate Oxygenation in Prostate Tumors (Exipox)
  “Slow inclusion rate due to patients operated before intervention is implementable” (76% match in meaning)
• The Clinical and Laboratory Phenotypes of Severe Asthma Patients in Clalit Health Services Haifa
  “Slow recruitment of patients” (73% match in meaning)
• Evaluation of the Parietex TM Parastomal No Hole Mesh for Repair of Parastomal Hernias in End-colostomies
  “too slow patiënts recruitment” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.